Investors may be wary of health care stocks heading into an election year where the future of health care in the U.S. will be hotly debated – and drug companies are likely to be the targets of heated rhetoric on both sides. However, Goldman Sachs believes that any changes will be “evolutionary rather than revolutionary” – and its strategists have identified three health care stocks set to outperform next year. For these three stocks, CLICK HERE.